AET02 Table 2 (Supplementary) Adverse Events by System Organ Class, High Level Term and Preferred Term Table 2aet02_2.RdThe AET02_2 table provides an overview of the number of patients experiencing adverse events and the number of
adverse events categorized by Body System, High Level Term and Dictionary-Derived Term.
aet02_2(
adam_db,
armvar = .study$actualarm,
lbl_overall = .study$lbl_overall,
prune_0 = TRUE,
deco = std_deco("AET02"),
.study = list(actualarm = "ACTARM", lbl_overall = NULL)
)
aet02_2_lyt(
armvar = .study$actualarm,
lbl_overall = .study$lbl_overall,
lbl_aebodsys = "AEBODSYS",
lbl_aehlt = "AEHLT",
lbl_aedecod = "AEDECOD",
deco = std_deco("AET02"),
.study = list(actualarm = "ACTARM", lbl_overall = NULL)
)
aet02_2_pre(adam_db)(dm) object containing the ADaM datasets
(character) variable used for column splitting
(character) label used for overall column, if set to NULL the overall column is omitted
(logical) remove 0 count rows
(character) decoration with title, subtitles and main_footer content
(list) with default values for the arguments of the function
(character) text label for AEBODSYS.
(character) text label for AEHLT.
(character) text label for AEDECOD.
Numbers represent absolute numbers of patients and fraction of N, or absolute number of event when specified.
Remove zero-count rows unless overridden with prune_0 = FALSE.
Split columns by arm.
Does not include a total column by default.
Sort Body System or Organ Class, High Level Term and Dictionary-Derived Term hierarchically by highest overall frequencies.
aet02_2_lyt: aet02_2 Layout
aet02_2_pre: aet02_2 Preprocessing
library(dm)
db <- syn_test_data() %>%
aet02_2_pre()
aet02_2(db) %>% head(15)
#> Adverse Events: {Specify Population}
#> Protocol: {{protocol}}
#>
#> ————————————————————————————————————————————————————————————————————————————————————————————————————————
#> A: Drug X B: Placebo C: Combination
#> (N=134) (N=134) (N=132)
#> ————————————————————————————————————————————————————————————————————————————————————————————————————————
#> Total number of patients with at least one adverse event 122 (91%) 123 (91.8%) 120 (90.9%)
#> Overall total number of events 609 622 703
#> cl A.1
#> Total number of patients with at least one adverse event 78 (58.2%) 75 (56%) 89 (67.4%)
#> Total number of events 132 130 160
#> hlt A.1.1.1
#> Total number of patients with at least one adverse event 78 (58.2%) 75 (56%) 89 (67.4%)
#> Total number of events 132 130 160
#> dcd A.1.1.1.1 50 (37.3%) 45 (33.6%) 63 (47.7%)
#> dcd A.1.1.1.2 48 (35.8%) 48 (35.8%) 50 (37.9%)
#> cl B.2
#> Total number of patients with at least one adverse event 79 (59%) 74 (55.2%) 85 (64.4%)
#> Total number of events 129 138 143
#> hlt B.2.2.3
#> Total number of patients with at least one adverse event 48 (35.8%) 54 (40.3%) 51 (38.6%)
#> ————————————————————————————————————————————————————————————————————————————————————————————————————————
#>
#> Investigator text for AEs encoded using MedDRA version xx.x. Percentages are based on N in the column headings. For frequency counts by preferred term, multiple occurrences of the same AE in an individual are counted only once. For frequency counts of "Total number of events" rows, multiple occurrences of the same AE in an individual are counted separately. Standard footnote defining AEs included in table (e.g., includes AEs with onset from first dose of study drug through 7 days after last dose of study drug).
# Additional Examples
aet02_2(db, lbl_overall = "All Patients") %>% head()
#> Adverse Events: {Specify Population}
#> Protocol: {{protocol}}
#>
#> —————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
#> A: Drug X B: Placebo C: Combination All Patients
#> (N=134) (N=134) (N=132) (N=400)
#> —————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
#> Total number of patients with at least one adverse event 122 (91%) 123 (91.8%) 120 (90.9%) 365 (91.2%)
#> Overall total number of events 609 622 703 1934
#> cl A.1
#> Total number of patients with at least one adverse event 78 (58.2%) 75 (56%) 89 (67.4%) 242 (60.5%)
#> Total number of events 132 130 160 422
#> hlt A.1.1.1
#> —————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
#>
#> Investigator text for AEs encoded using MedDRA version xx.x. Percentages are based on N in the column headings. For frequency counts by preferred term, multiple occurrences of the same AE in an individual are counted only once. For frequency counts of "Total number of events" rows, multiple occurrences of the same AE in an individual are counted separately. Standard footnote defining AEs included in table (e.g., includes AEs with onset from first dose of study drug through 7 days after last dose of study drug).
db_m <- db %>%
dm_zoom_to(adae) %>%
mutate(AEBODSYS = formatters::with_label(AEBODSYS, "MedDRA System Organ Class")) %>%
dm_update_zoomed()
aet02_2(db_m) %>% head()
#> Adverse Events: {Specify Population}
#> Protocol: {{protocol}}
#>
#> ——————————————————————————————————————————————————————————————————————————————————————————————————————
#> A: Drug X B: Placebo C: Combination
#> (N=134) (N=134) (N=132)
#> ——————————————————————————————————————————————————————————————————————————————————————————————————————
#> Total number of patients with at least one adverse event 122 (91%) 123 (91.8%) 120 (90.9%)
#> Overall total number of events 609 622 703
#> cl A.1
#> Total number of patients with at least one adverse event 78 (58.2%) 75 (56%) 89 (67.4%)
#> Total number of events 132 130 160
#> hlt A.1.1.1
#> ——————————————————————————————————————————————————————————————————————————————————————————————————————
#>
#> Investigator text for AEs encoded using MedDRA version xx.x. Percentages are based on N in the column headings. For frequency counts by preferred term, multiple occurrences of the same AE in an individual are counted only once. For frequency counts of "Total number of events" rows, multiple occurrences of the same AE in an individual are counted separately. Standard footnote defining AEs included in table (e.g., includes AEs with onset from first dose of study drug through 7 days after last dose of study drug).
aet02_2_lyt(
armvar = "ACTARM",
lbl_overall = NULL,
lbl_aebodsys = "Body System or Organ Class",
lbl_aehlt = "High Level Term",
lbl_aedecod = "Dictionary-Derived Term",
deco = std_deco("AET02")
)
#> A Pre-data Table Layout
#>
#> Column-Split Structure:
#> ACTARM (lvls)
#>
#> Row-Split Structure:
#> AEBODSYS (lvls) -> AEHLT (lvls) -> AEDECOD (** analysis **)
#>
syn_test_data() %>%
aet02_2_pre()
#> ── Metadata ────────────────────────────────────────────────────────────────────
#> Tables: `adsl`, `adae`, `adaette`, `adcm`, `addv`, … (15 total)
#> Columns: 846
#> Primary keys: 2
#> Foreign keys: 1